US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

UpStream Bio Inc.

9.71

+0.930010.59%

Pre-market: 9.53-0.1800-1.85%06:25 EDT

Volume:507.32K

Turnover:4.84M

Market Cap:520.85M

PE:-1.74

High:9.99

Open:8.73

Low:8.58

Close:8.78

Loading ...

Overview Company News Filings

We Think Upstream Bio (NASDAQ:UPB) Can Afford To Drive Business Growth

Simply Wall St.

Upstream Bio (NASDAQ:UPB) Is In A Good Position To Deliver On Growth Plans

Simply Wall St.

Upstream Bio, Inc.: Promising Outlook with Strategic Positioning and Strong Trial Execution

Upstream Bio’s Financial Results and Strategic Progress

Velocity Financial, Inc. Reports Fourth Quarter and Full Year 2024 Results

Piper Sandler Remains a Buy on Upstream Bio, Inc. (UPB)

Upstream Bio to Present at Upcoming March Investor Conferences

Arbor Realty Trust Reports Fourth Quarter and Full Year 2024 Results and Declares Dividend of $0.43 per Share

Automotive Security Leaders Must Take Immediate Action to Mitigate the Surging Cyber Threats--Upstream Report Reveals Critical Gaps

PennyMac Financial Services, Inc. Reports Fourth Quarter and Full-Year 2024 Results

TWO Reports Fourth Quarter 2024 Financial Results

London pubs giant targets new openings after sales success

Upstream Bio appoints Amrbose as General Counsel

Upstream Bio Appoints Allison Ambrose as General Counsel

THOMSON REUTERS

Press Release: Upstream Bio Appoints Allison Ambrose as General Counsel

Upstream Bio to be added to Russell 2000 Index

Upstream Bio Advances Clinical Trials, Strengthens Financials

Upstream Bio reports Q3 revenue $607,000 vs $621,000 last year

Velocity Financial, Inc. Reports Third Quarter 2024 Results

UWM delivers highest volume in three years amid mini refi boom

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/UPB/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"UPB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"UPB\",,,,,undefined,":{"symbol":"UPB","market":"US","secType":"STK","nameCN":"UpStream Bio Inc.","latestPrice":9.71,"timestamp":1745265600000,"preClose":8.78,"halted":0,"volume":507320,"hourTrading":{"tag":"盘前","latestPrice":9.53,"preClose":9.71,"latestTime":"06:25 EDT","volume":200,"amount":1913.0002000000002,"timestamp":1745317554542},"delay":0,"floatShares":31148945,"shares":53640895,"eps":-5.58348,"marketStatus":"Pre-Mkt","change":0.93,"latestTime":"04-22 07:16:02 EDT","open":8.73,"high":9.99,"low":8.58,"amount":4837443.83012,"amplitude":0.160592,"askPrice":11.77,"askSize":100,"bidPrice":5.13,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-5.58348,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1745328600000},"marketStatusCode":1,"adr":0,"listingDate":1728619200000,"exchange":"NASDAQ","adjPreClose":9.71,"preHourTrading":{"tag":"盘前","latestPrice":9.53,"preClose":9.71,"latestTime":"06:25 EDT","volume":200,"amount":1913.0002000000002,"timestamp":1745317554542},"postHourTrading":{"tag":"盘后","latestPrice":9.71,"preClose":9.71,"latestTime":"18:50 EDT","volume":1039,"amount":10102.14,"timestamp":1745275826980},"volumeRatio":1.893148453342583},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"UPB\",,,,,undefined,":{"symbol":"UPB","floatShares":31148945,"roa":"-16.23%","roe":"-21.74%","lyrEps":-5.58348,"volumeRatio":1.893148453342583,"shares":53640895,"dividePrice":0,"high":9.99,"amplitude":0.160592,"preClose":8.78,"low":8.58,"week52Low":5.14,"pbRate":"1.11","psRate":"219.77","week52High":29.4599,"institutionHeld":0,"latestPrice":9.71,"eps":-5.58348,"divideRate":0,"volume":507320,"delay":0,"ttmEps":-5.58348,"open":8.73,"prevYearClose":16.44,"prevWeekClose":8.78,"prevMonthClose":6.12,"prevQuarterClose":6.12,"fiveDayClose":7.37,"twentyDayClose":7.62,"sixtyDayClose":10.77},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"UPB\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2527984281","title":"We Think Upstream Bio (NASDAQ:UPB) Can Afford To Drive Business Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2527984281","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527984281?lang=en_us&edition=fundamental","pubTime":"2025-04-12 22:13","pubTimestamp":1744467212,"startTime":"0","endTime":"0","summary":"We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-upb/upstream-bio/news/we-think-upstream-bio-nasdaqupb-can-afford-to-drive-business","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["PSQ","TQQQ","BK4112","UPB","QID","IE00BKPKM429.USD","IE00B3QW5Z07.USD","SQQQ","MNQmain","BK4588",".IXIC","LU2095319765.USD","BK4585","QLD","TSYW.SI","IE00BGHQF748.EUR","IE00B64PRP62.GBP","USJW.SI","BK4139","LU2210150020.SGD","LU2210149790.SGD","NDAQ","USAW.SI","NVIW.SI","NQmain"],"gpt_icon":1},{"id":"2526052663","title":"Upstream Bio (NASDAQ:UPB) Is In A Good Position To Deliver On Growth Plans","url":"https://stock-news.laohu8.com/highlight/detail?id=2526052663","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526052663?lang=en_us&edition=fundamental","pubTime":"2025-04-11 19:52","pubTimestamp":1744372371,"startTime":"0","endTime":"0","summary":"There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although software-as-a-service business Salesforce.com lost money for years while it grew recurring revenue, if you held shares since 2005, you'd have done very well indeed. Nonetheless, only a fool would ignore the risk that a loss making company burns through its cash too quickly.So should Upstream Bio  shareholders be worried about its cash burn?For the purposes of this article, cash burn is the annual rate at which an unprofitable company spends cash to fund its growth; its negative free cash flow. Let's start with an examination of the business' cash, relative to its cash burn.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/upstream-bio-nasdaq-upb-good-115251508.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PSQ","QLD","SQQQ","IE00B64PRP62.GBP","USJW.SI","BK4585",".IXIC","IE00B3QW5Z07.USD","LU2095319765.USD","LU2210150020.SGD","BK4588","NVIW.SI","NDAQ","QID","IE00BKPKM429.USD","TSYW.SI","TQQQ","BK4139","USAW.SI","UPB","MNQmain","BK4112","IE00BGHQF748.EUR","LU2210149790.SGD","NQmain"],"gpt_icon":1},{"id":"2520113704","title":"Upstream Bio, Inc.: Promising Outlook with Strategic Positioning and Strong Trial Execution","url":"https://stock-news.laohu8.com/highlight/detail?id=2520113704","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520113704?lang=en_us&edition=fundamental","pubTime":"2025-03-20 06:45","pubTimestamp":1742424311,"startTime":"0","endTime":"0","summary":"William Blair analyst Matt Phipps has reiterated their bullish stance on UPB stock, giving a Buy rating on March 12. Matt Phipps’s rating is based ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/upstream-bio-inc-promising-outlook-with-strategic-positioning-and-strong-trial-execution?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/upstream-bio-inc-promising-outlook-with-strategic-positioning-and-strong-trial-execution?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","UPB"],"gpt_icon":0},{"id":"2519794610","title":"Upstream Bio’s Financial Results and Strategic Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2519794610","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519794610?lang=en_us&edition=fundamental","pubTime":"2025-03-13 12:12","pubTimestamp":1741839126,"startTime":"0","endTime":"0","summary":"Upstream Bio, Inc. ( ($UPB) ) has released its Q4 earnings. Here is a breakdown of the information Upstream Bio, Inc. presented to its investors. U...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/upstream-bios-financial-results-and-strategic-progress?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/upstream-bios-financial-results-and-strategic-progress?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","LU2065732104.USD","PRGS","UPB","BK4097"],"gpt_icon":0},{"id":"2517157041","title":"Velocity Financial, Inc. Reports Fourth Quarter and Full Year 2024 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2517157041","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517157041?lang=en_us&edition=fundamental","pubTime":"2025-03-07 05:10","pubTimestamp":1741295400,"startTime":"0","endTime":"0","summary":"Net income of $20.6 million, up 18.6% from $17.4 million for 4Q23. Diluted EPS of $0.57, up $0.07 from $0.50 per share for 4Q23. Core net income of $21.8 million, an increase of 34.6% from $16.2 million for 4Q23. Core diluted EPS of $0.60, up from $0.46 per share for 4Q23. Loan production of $563.5 million in UPB, an 18.2% and 60.0% increase from 3Q24 and 4Q23, respectively. Year-to-date 2025 loan production through February of $429.4 million. Nonperforming loans  as a percentage of Held for Investment  loans was 10.7%, up slightly from 10.6% as of September 30, 2024, and 9.7% as of December 31, 2023, respectively. Resolutions of NPL and real estate owned  totaled $79.4 million in UPB. Realized gains of $5.6 million or 107.0% of UPB resolved. Completed the VCC 2024-5 and VCC 2024-6 securitizations totaling $292.9 million and 293.9 million, respectively, of securities issued. Liquidity of $95.9 million and total available warehouse line capacity of $435.0 million as of December 31, 2024","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/velocity-financial-inc-reports-fourth-211000023.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["VEL","WAC","BK4195","BK4139","UPB","BK4229","NIM"],"gpt_icon":0},{"id":"2516064620","title":"Piper Sandler Remains a Buy on Upstream Bio, Inc. (UPB)","url":"https://stock-news.laohu8.com/highlight/detail?id=2516064620","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516064620?lang=en_us&edition=fundamental","pubTime":"2025-03-04 19:49","pubTimestamp":1741088968,"startTime":"0","endTime":"0","summary":"In a report released today, Yasmeen Rahimi from Piper Sandler maintained a Buy rating on Upstream Bio, Inc. (UPB – Research Report), with a price t...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/piper-sandler-remains-a-buy-on-upstream-bio-inc-upb-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/piper-sandler-remains-a-buy-on-upstream-bio-inc-upb-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","UPB"],"gpt_icon":0},{"id":"2514099352","title":"Upstream Bio to Present at Upcoming March Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2514099352","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514099352?lang=en_us&edition=fundamental","pubTime":"2025-02-25 21:00","pubTimestamp":1740488400,"startTime":"0","endTime":"0","summary":"WALTHAM, Mass., Feb. 25, 2025  -- Upstream Bio, Inc. , a clinical-stage company developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders, today announced that Rand Sutherland, MD, Upstream Bio’s CEO, will present at the following upcoming March investor conferences:. TD Cowen 45th Annual Health Care Conference, Boston MATuesday, March 4, 2025, 11:50 a.m. – 12:20 p.m. ET. Leerink Partners Global Biopharma Conference 2025, Miami FLWednesday, March 12, 2025, 1:40 p.m. – 2:10 p.m. ET. A live webcast of the presentation will be available under the “Events” tab on the “Investors” page of the Company's website on the day of the event. A replay of the webcast will be posted on the Company's website following the presentation.Investor Contact:Michael GrayChief Financial Officer and Chief Operating Officerir@upstreambio.com","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/upstream-bio-present-upcoming-march-130000152.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","UPB"],"gpt_icon":0},{"id":"2513603192","title":"Arbor Realty Trust Reports Fourth Quarter and Full Year 2024 Results and Declares Dividend of $0.43 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2513603192","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513603192?lang=en_us&edition=fundamental","pubTime":"2025-02-21 21:15","pubTimestamp":1740143700,"startTime":"0","endTime":"0","summary":"Fourth Quarter Highlights: GAAP net income of $0.32 and distributable earnings of $0.40, per diluted common share1Declares cash dividend on common stock of $0.43 per shareAgency loan originations of $","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/02/21/3030434/0/en/Arbor-Realty-Trust-Reports-Fourth-Quarter-and-Full-Year-2024-Results-and-Declares-Dividend-of-0-43-per-Share.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4110","BK4139","ABR","UPB"],"gpt_icon":0},{"id":"2510384416","title":"Automotive Security Leaders Must Take Immediate Action to Mitigate the Surging Cyber Threats--Upstream Report Reveals Critical Gaps","url":"https://stock-news.laohu8.com/highlight/detail?id=2510384416","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510384416?lang=en_us&edition=fundamental","pubTime":"2025-02-11 22:00","pubTimestamp":1739282400,"startTime":"0","endTime":"0","summary":"Upstream's 2025 Automotive & Smart Mobility Cybersecurity Report reveals that 60% of cyber incidents could affect thousands to millions of connected vehicles, with massive-scale attacks more than tripling; the report emphasizes that current regulatory requirements are insufficient to address expanding cyber risks.The report revealed that in 2024, 60% of cybersecurity incidents in the automotive and smart mobility sectors affected thousands to millions of mobility assets, including vehicles, EV charging stations, smart mobility apps, and connected devices. Notably, massive-scale incidents—each impacting millions of vehicles—more than tripled, rising from 5% in 2023 to 19% in 2024. This sharp increase highlights the urgent need for organizations to prioritize resilience by extending their cybersecurity efforts beyond regulatory compliance.Cyberattacks in 2024 became more sophisticated and frequent, targeting vehicles and backend systems, as well as smart mobility platforms, devices, and","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/automotive-security-leaders-must-immediate-140000730.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/automotive-security-leaders-must-immediate-140000730.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","UPB"],"gpt_icon":0},{"id":"2507053603","title":"PennyMac Financial Services, Inc. Reports Fourth Quarter and Full-Year 2024 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2507053603","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507053603?lang=en_us&edition=fundamental","pubTime":"2025-01-31 05:14","pubTimestamp":1738271640,"startTime":"0","endTime":"0","summary":"WESTLAKE VILLAGE, Calif., January 30, 2025----PennyMac Financial Services, Inc.  today reported net income of $104.5 million for the fourth quarter of 2024, or $1.95 per share on a diluted basis, on revenue of $470.1 million. Book value per share increased to $74.54 from $72.95 at September 30, 2024.PFSI’s Board of Directors declared a fourth quarter cash dividend of $0.30 per share, payable on February 23, 2025, to common stockholders of record as of February 13, 2025.In the fourth quarter, management reassessed its segment definitions. Prior period amounts have been recast to conform those periods' presentation to current period presentation. Non-segment activities are included under \"Corporate and other\" and include amounts attributable to corporate activities not directly attributable to the production and servicing segments as well as management fees earned from PennyMac Mortgage Investment Trust .Pretax income excluding valuation-related changes was $168.3 million, essentially un","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/pennymac-financial-services-inc-reports-211400646.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PMT","BK4195","BK4139","UPB","BK4229","BK4110","PFSI"],"gpt_icon":0},{"id":"2507654726","title":"TWO Reports Fourth Quarter 2024 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2507654726","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507654726?lang=en_us&edition=fundamental","pubTime":"2025-01-30 05:15","pubTimestamp":1738185300,"startTime":"0","endTime":"0","summary":"Hedged MSR Strategy Drives High-Quality Returns in Dynamic Market. NEW YORK, January 29, 2025----TWO , an MSR-focused real estate investment trust , today announced its financial results for the quarter ended December 31, 2024.Reported book value of $14.47 per common share, and declared a fourth quarter common stock dividend of $0.45 per share, representing a flat quarterly economic return on book value.Settled $2.5 billion in unpaid principal balance  of MSR through bulk and flow-sale acquisitions and recapture.MSR portfolio had 3-month CPR of 4.93%, weighted average gross coupon rate of 3.46%, and 60+ day delinquency rate of 0.90%.\"Mortgage spread volatility has significantly decreased, enhancing our portfolio’s return outlook,\" stated Nick Letica, TWO’s Chief Investment Officer. \"Mortgage rates are well above 6%, and prepayment rates are expected to remain slow in 2025, providing a strong positive tailwind for MSR. Combined with historically wide nominal current coupon spreads, we b","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/two-reports-fourth-quarter-2024-211500900.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["UPB","TWO","REIT","BK4139","BK4110"],"gpt_icon":0},{"id":"2506532449","title":"London pubs giant targets new openings after sales success","url":"https://stock-news.laohu8.com/highlight/detail?id=2506532449","media":"cityam","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506532449?lang=en_us&edition=fundamental","pubTime":"2025-01-27 17:19","pubTimestamp":1737969555,"startTime":"0","endTime":"0","summary":"The London pubs group has reported a surge in sales.  One of London’s largest independent pubs and dining groups is preparing for further expansion after reporting a jump in sales for its latest financial year.Urban Pubs & Bars  has announced that its turnover increased by 16 per cent to 60.5m in the 12 months to 28 April, 2024. The group added that the total was also a four per cent rise in its like-for-like sales.UPB, which runs operates 53 pubs, bars and restaurants across London, added that its EBITDA [earnings before interest, taxes, depreciation and amortisation] grew by 26 per cent to 8.7m in the year.The London pubs group has not revealed how much pre-tax profit it achieved in the year. For 2023, that figure stood at 362,262.","market":"fut","thumbnail":"https://www.cityam.com/wp-content/uploads/2025/01/GettyImages-2173711454-2.jpg?w=286&h=161&crop=1","type":0,"news_type":0,"thumbnails":["https://www.cityam.com/wp-content/uploads/2025/01/GettyImages-2173711454-2.jpg?w=286&h=161&crop=1"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.cityam.com/london-pubs-giant-targets-new-openings-after-sales-success/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"cityam_highlight","symbols":["UPB","BK4139"],"gpt_icon":0},{"id":"2492195472","title":"Upstream Bio appoints Amrbose as General Counsel","url":"https://stock-news.laohu8.com/highlight/detail?id=2492195472","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492195472?lang=en_us&edition=fundamental","pubTime":"2024-12-17 21:11","pubTimestamp":1734441085,"startTime":"0","endTime":"0","summary":"Upstream Bio (UPB) announced that the Company has appointed Allison Ambrose, J.D. as General Counsel. Ambrose is a senior legal leader with more th...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/upstream-bio-appoints-amrbose-as-general-counsel?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/upstream-bio-appoints-amrbose-as-general-counsel?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["UPB","BK4139"],"gpt_icon":0},{"id":"2492360954","title":"Upstream Bio Appoints Allison Ambrose as General Counsel","url":"https://stock-news.laohu8.com/highlight/detail?id=2492360954","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492360954?lang=en_us&edition=fundamental","pubTime":"2024-12-17 21:00","pubTimestamp":1734440402,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241217:nTUA7CS6WB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["UPB","BK4139"],"gpt_icon":0},{"id":"2492951047","title":"Press Release: Upstream Bio Appoints Allison Ambrose as General Counsel","url":"https://stock-news.laohu8.com/highlight/detail?id=2492951047","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492951047?lang=en_us&edition=fundamental","pubTime":"2024-12-17 21:00","pubTimestamp":1734440400,"startTime":"0","endTime":"0","summary":"WALTHAM, Mass., Dec. 17, 2024  -- Upstream Bio, Inc. , a clinical-stage company developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders, today announced that the Company has appointed Allison Ambrose, J.D. as General Counsel. Ms. Ambrose is a senior legal leader with more than 15 years of experience providing counsel on a wide range of matters including corporate governance, securities law and compliance, and capital markets and corporate development transactions. Ms. Ambrose will oversee all aspects of Upstream's legal function and join the Company's executive leadership team.\"I am thrilled to welcome Allison to the Upstream Bio team,\" said Rand Sutherland, M.D., Upstream Bio's Chief Executive Officer. \"Allison's extensive experience in the biotech industry has come from helping numerous growth-stage companies work towards their business goals. Her legal and strategic counsel will be critically important as we optimize the Company to focu","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["UPB","BK4139"],"gpt_icon":0},{"id":"2491918696","title":"Upstream Bio to be added to Russell 2000 Index","url":"https://stock-news.laohu8.com/highlight/detail?id=2491918696","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491918696?lang=en_us&edition=fundamental","pubTime":"2024-12-16 21:35","pubTimestamp":1734356107,"startTime":"0","endTime":"0","summary":"Upstream Bio (UPB) announced that the Company will be added to the Russell 2000 index as part of the planned fourth quarter initial public offering...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/upstream-bio-to-be-added-to-russell-2000-index?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/upstream-bio-to-be-added-to-russell-2000-index?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","UPB"],"gpt_icon":0},{"id":"2482941164","title":"Upstream Bio Advances Clinical Trials, Strengthens Financials","url":"https://stock-news.laohu8.com/highlight/detail?id=2482941164","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482941164?lang=en_us&edition=fundamental","pubTime":"2024-11-09 12:29","pubTimestamp":1731126553,"startTime":"0","endTime":"0","summary":"Upstream Bio, Inc. ( ($UPB) ) has released its Q3 earnings. Here is a breakdown of the information Upstream Bio, Inc. presented to its investors. U...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/upstream-bio-advances-clinical-trials-strengthens-financials?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/upstream-bio-advances-clinical-trials-strengthens-financials?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","UPB"],"gpt_icon":0},{"id":"2481179360","title":"Upstream Bio reports Q3 revenue $607,000 vs $621,000 last year","url":"https://stock-news.laohu8.com/highlight/detail?id=2481179360","media":"TipRanks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481179360?lang=en_us&edition=fundamental","pubTime":"2024-11-08 20:11","pubTimestamp":1731067907,"startTime":"0","endTime":"0","summary":"“At Upstream Bio , we continue to make significant progress toward developing verekitug, the only monoclonal antibody currently in clinical development that targets and inhibits the thymic stromal lymphopoietin receptor, in severe respiratory diseases with substantial unmet needs. We expect to report top-line data from our ongoing Phase 2 clinical trials in severe asthma and chronic rhinosinusitis with nasal polyps in the second half of 2026 and the second half of 2025, respectively. In addition, we have initiated planning activities for a Phase 2 clinical trial in chronic obstructive pulmonary disease, and we anticipate dosing our first patient in this program in the second half of 2025,” said Rand Sutherland, M.D., Upstream Bio’s Chief Executive Officer. “Our recently completed initial public offering has provided us with sufficient capital to fund our planned operations through 2027, which will support our strategy of leveraging verekitug’s unique mechanism of action to improve trea","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/6MInUe1T4fs5TaG11G3efw--~B/aD0xOTI7dz0xOTI7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/tipranks_452/87b9ff78d08b9d461f46ab67f57ff730","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/6MInUe1T4fs5TaG11G3efw--~B/aD0xOTI7dz0xOTI7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/tipranks_452/87b9ff78d08b9d461f46ab67f57ff730"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/upstream-bio-reports-q3-revenue-121147062.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/upstream-bio-reports-q3-revenue-121147062.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["UPB"],"gpt_icon":0},{"id":"2481922881","title":"Velocity Financial, Inc. Reports Third Quarter 2024 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2481922881","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481922881?lang=en_us&edition=fundamental","pubTime":"2024-11-08 05:15","pubTimestamp":1731014100,"startTime":"0","endTime":"0","summary":"Net income of $15.8 million, up 30.8% from $12.1 million for 3Q23. Diluted EPS of $0.44, up $0.09 from $0.35 per share for 3Q23. Core net income of $16.9 million, an increase of 31.2% from $12.9 million for 3Q23. Core diluted EPS of $0.47, up from $0.37 per share for 3Q23. Loan production of $476.8 million in UPB, a 12.9% and 64.1% increase from 2Q24 and 3Q23, respectively. Nonperforming loans as a percentage of Held for Investment  loans was 10.6%, up slightly from 10.5% as of June 30, 2024, and 10.1% as of September 30, 2023, respectively. Resolutions of nonperforming loans  and real estate owned  totaled $68.6 million in UPB. Realized gains of $2.3 million or 103.4% of UPB resolved. Portfolio net interest margin  of 3.60%, an increase of 6 bps Q/Q and 26 bps from 3.34% for 3Q23. Liquidity of $92.8 million and total available warehouse line capacity of $349.3 million as of September 30, 2024","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/YtyKjsvpHym4zKOg3hLNtQ--~B/aD01MTI7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/f581c12437b391ee823796d1d6e5cecd","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/YtyKjsvpHym4zKOg3hLNtQ--~B/aD01MTI7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/f581c12437b391ee823796d1d6e5cecd"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/velocity-financial-inc-reports-third-211500007.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4229","BK4195","NIM","VEL","UPB","WAC","BK4139"],"gpt_icon":0},{"id":"2481192283","title":"UWM delivers highest volume in three years amid mini refi boom","url":"https://stock-news.laohu8.com/highlight/detail?id=2481192283","media":"HousingWire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481192283?lang=en_us&edition=fundamental","pubTime":"2024-11-08 00:16","pubTimestamp":1730996193,"startTime":"0","endTime":"0","summary":"When rates dropped in the third quarter of 2024, UWM Holdings Corp., the parent of United Wholesale Mortgage, notched its biggest production quarter in three years while improving margins due to a higher refi volume. However, it also made a more modest profit, mainly because of the financial impact of lower rates on its servicing book.“The refi boom is not fully materialized, but we have seen a preview of it,” Mat Ishbia, chairman and CEO of UWM, told analysts during an earnings call on Thursday morning. “We’re able to capitalize on it instantly, while others were caught flat-footed.”According to documents filed with the Securities and Exchange Commission , the Pontiac, Michigan-based company reported a non-GAAP net income of $23.3 million during the third quarter of 2024, compared to $59.8 million in the previous quarter.“We all believe that the 10-year [Treasury yield] will be down below 4% and 3.75% over the next 6, 12, 18 months, potentially longer,” Ishbia said. “And you can kind ","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/DXLzzwo5YdBp4sPLLLFeXg--~B/aD02NzU7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/hw_media_articles_462/cf3aeee5e490719fe025263aeb3e78dc","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/DXLzzwo5YdBp4sPLLLFeXg--~B/aD02NzU7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/hw_media_articles_462/cf3aeee5e490719fe025263aeb3e78dc"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/uwm-delivers-highest-volume-three-161633828.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4195","UPB","BK4229","UWMC","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":38,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/UPB\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-12","symbol":"UPB","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1741752000000,"reportTimeType":"pre","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"UPB\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"UPB\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.25,"buy":0.75,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.75,"analysts":4,"updateTime":1731211200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/UPB\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"UPB","date":"2025-04-21","current":-7.498759,"percent":0.79845,"low":-36.237602,"twenty":-23.872906,"median":-11.362315,"eighty":-7.496584,"high":-5.184222,"avg":-15.78471,"sd":9.221834,"marketCap":470967058},"quantilePoints":[{"date":"2024-10-11","current":-21.547111,"twenty":-21.096119,"median":-20.419631,"eighty":-19.743142,"marketCap":872808815},{"date":"2024-10-18","current":-29.91246,"twenty":-29.856691,"median":-29.151973,"eighty":-22.814588,"marketCap":1211664002},{"date":"2024-10-25","current":-33.154958,"twenty":-33.128498,"median":-29.931472,"eighty":-28.137991,"marketCap":1343007876},{"date":"2024-10-31","current":-32.943274,"twenty":-33.154958,"median":-32.429578,"eighty":-29.151973,"marketCap":1334433205},{"date":"2024-11-08","current":-35.748083,"twenty":-33.28726,"median":-32.943274,"eighty":-29.633615,"marketCap":1448047598},{"date":"2024-11-15","current":-26.036965,"twenty":-33.27403,"median":-32.40745,"eighty":-26.47861,"marketCap":1390295829},{"date":"2024-11-22","current":-17.866537,"twenty":-33.154958,"median":-29.91246,"eighty":-25.555171,"marketCap":954019497},{"date":"2024-11-29","current":-21.951751,"twenty":-33.154958,"median":-29.151973,"eighty":-21.870823,"marketCap":1172157663},{"date":"2024-12-06","current":-22.082237,"twenty":-33.144374,"median":-26.689395,"eighty":-21.903572,"marketCap":1179125222},{"date":"2024-12-13","current":-20.486294,"twenty":-33.088806,"median":-26.036965,"eighty":-21.589777,"marketCap":1093906626},{"date":"2024-12-20","current":-16.672089,"twenty":-32.969734,"median":-24.742143,"eighty":-20.201232,"marketCap":890239542},{"date":"2024-12-27","current":-19.517686,"twenty":-32.858694,"median":-23.382078,"eighty":-19.472518,"marketCap":1042185906},{"date":"2025-01-03","current":-16.36093,"twenty":-32.784605,"median":-22.553994,"eighty":-19.153329,"marketCap":873624596},{"date":"2025-01-10","current":-16.250519,"twenty":-32.617811,"median":-22.077219,"eighty":-18.486847,"marketCap":867728970},{"date":"2025-01-17","current":-10.92067,"twenty":-31.635576,"median":-21.951751,"eighty":-17.320504,"marketCap":583131018},{"date":"2025-01-24","current":-10.810259,"twenty":-29.950484,"median":-21.600443,"eighty":-16.501454,"marketCap":577235392},{"date":"2025-01-31","current":-11.041119,"twenty":-29.91246,"median":-20.852659,"eighty":-16.230444,"marketCap":589562611},{"date":"2025-02-07","current":-8.561886,"twenty":-29.633615,"median":-19.703378,"eighty":-11.472726,"marketCap":457179006},{"date":"2025-02-14","current":-7.3574,"twenty":-29.151973,"median":-19.472518,"eighty":-10.92067,"marketCap":392863085},{"date":"2025-02-21","current":-8.260764,"twenty":-28.137991,"median":-19.276941,"eighty":-10.810259,"marketCap":441100026},{"date":"2025-02-28","current":-7.839194,"twenty":-27.097043,"median":-19.030874,"eighty":-9.965112,"marketCap":418589453},{"date":"2025-03-07","current":-8.451474,"twenty":-26.562924,"median":-18.338294,"eighty":-8.834903,"marketCap":451283380},{"date":"2025-03-14","current":-7.737899,"twenty":-26.318012,"median":-17.866537,"eighty":-8.491624,"marketCap":485986508},{"date":"2025-03-21","current":-6.875286,"twenty":-26.085144,"median":-16.857781,"eighty":-8.411325,"marketCap":431809204},{"date":"2025-03-28","current":-5.816236,"twenty":-26.012875,"median":-16.36093,"eighty":-8.168077,"marketCap":365294494},{"date":"2025-04-04","current":-5.380659,"twenty":-25.645507,"median":-16.240482,"eighty":-7.936302,"marketCap":337937638},{"date":"2025-04-11","current":-5.466066,"twenty":-24.254326,"median":-13.751211,"eighty":-7.734483,"marketCap":343301728},{"date":"2025-04-17","current":-7.191293,"twenty":-23.886958,"median":-11.472726,"eighty":-7.5722,"marketCap":451656335},{"date":"2025-04-21","current":-7.498759,"twenty":-23.872906,"median":-11.362315,"eighty":-7.496584,"marketCap":470967058}],"updateTime":1745320562381}}}